Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study-Reference-Cited by-同舟云学术

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Published:2021-05 Issue: Volume:235 Page:12-23
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Capell Warren H.^ORCID,Barnathan Elliot S.,Piazza Gregory,Spyropoulos Alex C.,Hsia Judith,Bull Scott,Lipardi Concetta,Sugarmann Chiara,Suh Eunyoung,Rao Jaya Prakash,Hiatt William R.,Bonaca Marc P.

Funder

Janssen Research and Development LLC

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy;Onder;JAMA,2020

2. COVID-19 and multiorgan response;Zaim;Curr Probl Cardiol,2020

3. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;Rothan;J Autoimmun,2020

4. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020

5. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia;Cui;J Thromb Haemost,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ecofriendly bioanalytical validated RP-HPLC method for simultaneous determination of COVID-19 co-prescribed drugs employing quality by design and green chemistry;Microchemical Journal;2024-05

2. Binary and ternary approach of solubility of Rivaroxaban for preparation of developed nano drug using supercritical fluid;Arabian Journal of Chemistry;2024-04

3. Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval;Journal of Korean Medical Science;2024

4. Poor regulation, desperation, and misinformation, a countrywide analysis of self-medication and prescription patterns in Ecuador during the COVID-19 pandemic;Research in Social and Administrative Pharmacy;2023-12

5. Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials;Thrombosis and Haemostasis;2023-11-23